Randomized Pragmatic Clinical Trial in a Community-Based Setting Comparing STIOLTO® RESPIMAT® vs. ICS-LABA Plus LAMA in Patients With COPD
Phase of Trial: Phase IV
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary) ; Budesonide/formoterol/glycopyrrolate
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms AIRWISE
- Sponsors Boehringer Ingelheim
- 22 Mar 2018 Last checked against ClinicalTrials.gov record
- 23 Jan 2018 Planned End Date changed from 23 Jan 2020 to 23 Jun 2020.
- 23 Jan 2018 Planned primary completion date changed from 23 Jan 2020 to 23 Jun 2020.